Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo
Zymeworks Inc. logo

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc), ZYME (Zymeworks Inc.) and more on Quantisnow.